Telix Pharmaceuticals (TLX) Inventory (2023 - 2026)

Telix Pharmaceuticals (TLX) has reported Inventory for 3 consecutive years, with $37.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Inventory rose 48.65% year-over-year to $37.1 million; the TTM figure through Dec 2025 stood at $37.1 million (up 48.65% YoY), while the FY2025 annual figure was $37.1 million, up 56.99% from the prior year.
• Inventory advanced to $37.1 million in Q4 2025 per TLX's latest filing, from $24.9 million in the prior quarter.
• Across five years, Inventory topped out at $37.1 million in Q4 2025 and bottomed at $11.3 million in Q4 2023.
• Historically, Inventory has averaged $24.4 million across 3 years, with a median of $24.9 million in 2024.
• Annual changes were most pronounced in 2024 — Inventory jumped 121.36% — and 2025, when it jumped 48.65%.
• Telix Pharmaceuticals' Inventory stood at $11.3 million in 2023, then surged by 121.36% to $24.9 million in 2024, then soared by 48.65% to $37.1 million in 2025.
• Business Quant data shows TLX's Inventory at $37.1 million in Q4 2025, $24.9 million in Q4 2024, and $11.3 million in Q4 2023.